Safety of the inactivated Japanese encephalitis virus vaccine IXIARO in children: An open-label, randomized, active-controlled, phase 3 study
The Pediatric Infectious Disease Journal Aug 24, 2017
Dubischar, KL, et al. – The safety profile of the Japanese encephalitis virus vaccine IXIARO (Valneva Austria GmbH, Vienna, Austria) was explored in a pediatric population. Accumulated evidence suggested that the safety profile of IXIARO was comparable to the control vaccines in terms of overall adverse event (AE) rates, serious AEs and medically attended AEs.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
